Tag Archive for: BioNTech

Covid-19: The Industry Response – How Are we Doing?

Chair: Clive Cookson, Science Editor, Financial Times Sean Marett, Chief Business and Chief Commercial Officer, BioNTech Professor James Logan, Head of Department of Disease Control, London School of Hygiene and Tropical Medicine Kate Bingham, Chair of UK Vaccine Taskforce & Managing Partner of SV Health Investors Rajeev Venkayya, MD, President Global Vaccine Business Unit, Takeda […]

Optimum’s 12th Annual Healthcare Investor Conference

co-hosted with Dechert LLP, Thursday 8th October 2020. The first speakers to be announced…